本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ayala Pharmaceuticals, Inc.

0.0333
+0.0000
成交量:20.00
成交額:0.67
市值:141.84萬
市盈率:0.00
高:0.0333
開:0.0333
低:0.0333
收:0.0333
資料載入中...
2024/04/26

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/19

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/04/16

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/15

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/04/15

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/04/15

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/04/15

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/04/15

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/04/15

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/04/15

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/04/15

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/04/15

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/04/03

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

重要事件披露

Form 8-K - Current report